International audienceHypoglycin A (HGA) is a toxin contained in seeds of the sycamore maple tree ( Acer pseudoplatanus ). Ingestion of this amino acid causes equine atypical myopathy (AM) in Europe. Another variety, A. negundo, is claimed to be present where AM cases were reported in the US. For unknown reasons, occurrence of this disease has increased. It is important to define environmental key factors that may influence toxicity of samaras from Acer species. In addition, the content of HGA in seedlings needs to be determined since AM outbreaks, during autumn period when the seeds fall but also during spring when seeds are germinating. The present study aims to validate a reliable method using high performance thin layer chromatography f...
Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPG) are naturally-occurring amino acids known ...
Atypical myopathy (AM) in horses is caused by ingestion of seeds of the Acer species (Sapindaceae fa...
Background: Hypoglycin A has been recently identified has the causal agent of atypical myopathy (AM)...
Hypoglycin A (HGA) is a toxin contained in seeds of the sycamore maple tree (Acer pseudoplatanus). I...
Hypoglycin A (HGA) is the toxic principle in ackee (Blighia sapida Koenig), a nutritious and readily...
Hypoglycin A (HGA) toxicity, following ingestion of material from certain plants, is linked to an ac...
Hypoglycin A (HGA) is the toxic principle in ackee (Blighia sapida Koenig), a nutritious and readily...
Hypoglycin A (HGA) toxicity, following ingestion of material from certain plants, is linked to an ac...
International audienceEquine atypical myopathy in Europe results from hypoglycin A (HGA) exposure th...
BACKGROUND Hypoglycin A, found in seeds of Acer negundo, appears to cause seasonal pasture myopat...
BACKGROUND: Atypical myopathy (AM) in horses is caused by the plant toxin hypoglycin A, which in Eur...
<div><p>Hypoglycin A (HGA) in seeds of <i>Acer spp</i>. is suspected to cause seasonal pasture myopa...
Hypoglycin A (HGA) in seeds of Acer spp. is suspected to cause seasonal pasture myopathy in North Am...
CASE HISTORY AND CLINICAL FINDINGS: During April and May 2014 four horses aged between 5 months and ...
The Acer (maple) genus of trees comprises over 120 species worldwide. Some of these contain the plan...
Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPG) are naturally-occurring amino acids known ...
Atypical myopathy (AM) in horses is caused by ingestion of seeds of the Acer species (Sapindaceae fa...
Background: Hypoglycin A has been recently identified has the causal agent of atypical myopathy (AM)...
Hypoglycin A (HGA) is a toxin contained in seeds of the sycamore maple tree (Acer pseudoplatanus). I...
Hypoglycin A (HGA) is the toxic principle in ackee (Blighia sapida Koenig), a nutritious and readily...
Hypoglycin A (HGA) toxicity, following ingestion of material from certain plants, is linked to an ac...
Hypoglycin A (HGA) is the toxic principle in ackee (Blighia sapida Koenig), a nutritious and readily...
Hypoglycin A (HGA) toxicity, following ingestion of material from certain plants, is linked to an ac...
International audienceEquine atypical myopathy in Europe results from hypoglycin A (HGA) exposure th...
BACKGROUND Hypoglycin A, found in seeds of Acer negundo, appears to cause seasonal pasture myopat...
BACKGROUND: Atypical myopathy (AM) in horses is caused by the plant toxin hypoglycin A, which in Eur...
<div><p>Hypoglycin A (HGA) in seeds of <i>Acer spp</i>. is suspected to cause seasonal pasture myopa...
Hypoglycin A (HGA) in seeds of Acer spp. is suspected to cause seasonal pasture myopathy in North Am...
CASE HISTORY AND CLINICAL FINDINGS: During April and May 2014 four horses aged between 5 months and ...
The Acer (maple) genus of trees comprises over 120 species worldwide. Some of these contain the plan...
Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPG) are naturally-occurring amino acids known ...
Atypical myopathy (AM) in horses is caused by ingestion of seeds of the Acer species (Sapindaceae fa...
Background: Hypoglycin A has been recently identified has the causal agent of atypical myopathy (AM)...